Oral administration of transgenic barley expressing a Culicoides allergen induces specific antibody response.
Authors: Jonsdottir S, Svansson V, Stefansdottir S B, Mäntylä E, Marti E, Torsteinsdottir S
Journal: Equine veterinary journal
Summary
# Editorial Summary Insect bite hypersensitivity (IBH) represents a significant welfare and economic concern in equine practice, triggered by IgE-mediated responses to Culicoides allergens; horses with early-life exposure develop tolerance, whilst those without develop severe reactions upon encounter. Researchers investigated whether oral immunisation using transgenic barley expressing a Culicoides allergen could generate protective antibody responses in naïve horses, administering the modified barley to a group of animals and measuring specific anti-allergen antibody titres over time. The transgenic barley successfully induced detectable specific antibody responses, establishing proof-of-concept that oral delivery of recombinant allergens could modulate immune tolerance to Culicoides antigens. This approach offers a promising strategy for preventing IBH in horses with no prior exposure to midges—particularly relevant for Icelandic and other northern European populations—potentially eliminating the need for symptomatic management alone and providing a practical, cost-effective immunotherapeutic intervention prior to at-risk animals' travel to endemic regions.
Read the full abstract on PubMed
Practical Takeaways
- •Oral immunotherapy using transgenic plants may offer a non-invasive alternative to traditional injectable immunotherapy for managing Culicoides hypersensitivity in horses
- •This approach could be particularly beneficial for horses with insect bite hypersensitivity that develop the condition after export from non-endemic regions like Iceland
- •Further clinical validation is needed before recommending transgenic barley as a standard treatment protocol for equine allergic dermatitis
Key Findings
- •Transgenic barley expressing Culicoides allergen was administered orally to investigate immunotherapy potential for insect bite hypersensitivity in horses
- •Study demonstrates feasibility of using genetically modified plant material as an oral delivery vehicle for allergen immunotherapy in equine medicine
- •Specific antibody response was induced through oral administration of transgenic barley expressing allergen